Shijiazhuang Dingmin pharmaceutical Sciences Co.,Ltd
sales@dingminpharma.com
86-311-67591193
Product Categories
(Total 12 Products for Pf 06463922 Cas No 1454846 35 5)
Lorlatinib (PF-6463922) intermediate 99% CAS 1454848-00-0
Lorlatinib (PF-06463922) intermediates 99% CAS 1454848-00-0 Name: methyl(R)-2-(1-((2-amino-5-bromopyridin-3-yl)oxy)ethyl)-4-fluorobenzoate CAS: 1454848-00-0
Lorlatinib intermediate PF-06463922 CAS 1454846-35-5
Lorlatinib intermediates PF-06463922 CAS 1454846-35-5 Lorlatinib (PF-6463922) is an anti-neoplastic drug for the treatment of non-small cell lung cancer. Name: PF-06463922, Lorlatinib CAS: 1454846-35-5
CAS NO.877399-52-5 Crizotinib 99.5%
High Purity Best Price CAS NO. 877399-52-5 Crizotinib Powder Crizotinib is a targeted therapy drug for non-small cell lung cancer developed by Pfizer Pharmaceuticals of the United States. The brand name is secure. Secure is a cutting-edge and epoch-making drug in the field of lung cancer targeted therapy. It was...
Dacomitinib (PF299804) CAS NO.1110813-31-4
Dacomitinib (PF299804) CAS NO.1110813-31-4 Pharmaceutical Grade : Product Name: Dacomitinib (PF299804) CAS No: 1110813-31-4 Appearence: Off-white to white powder Purity: 99%+
Molecular Formula:
99% Crizotinib CAS 877399-52-5
Crizotinib (trade name Xalkori, Pfizer) is an anti-cancer drug acting as an ALK (anaplastic lymphoma kinase) and ROS1 (c-ros oncogene 1) inhibitor, approved for treatment of some non-small cell lung carcinoma (NSCLC) in the US and some other countries, and undergoing clinical trials testing its safety and efficacy in...
Crizotinib (trade name Xalkori, Pfizer) is an anti-cancer drug acting as an ALK (anaplastic lymphoma kinase) and ROS1 (c-ros oncogene 1) inhibitor, approved for treatment of some non-small cell lung carcinoma (NSCLC) in the US and some other countries, and undergoing clinical trials testing its safety and efficacy in...
CAS NO.877399-52-5 Crizotinib 99.5%
High Purity Best Price CAS NO. 877399-52-5 Crizotinib Powder Crizotinib is a targeted therapy drug for non-small cell lung cancer developed by Pfizer Pharmaceuticals of the United States. The brand name is secure. Secure is a cutting-edge and epoch-making drug in the field of lung cancer targeted therapy. It was...
Pharmaceutical Crizotinib 877399-52-5
Product Description Crizotinib (trade name Xalkori, Pfizer) is an anti-cancer drug acting as an ALK (anaplastic lymphoma kinase) and ROS1 (c-ros oncogene 1) inhibitor, approved for treatment of some non-small cell lung carcinoma (NSCLC) in the US and some other countries, and undergoing clinical trials testing its...
CAS:1454846-35-5 Loratinib 99%
Loratinib API 99% PF0643922 PF-06463922 (10R)-7-Amino-12-fluoro-10,15,16,17-tetrahydro-2,10,16-trimethyl-15-oxo-2H-4,8-methenopyrazolo[4,3-h][2,5,11]benzoxadiazacyclotetradecine-3-carbonitrile Lorlatinib,PF-06463922 PF-06463922, Lorlatinib
Tafamidis 99% Tafamidis (Fx1006A)Tafamidis free acidPF-06291826(Tafamidis)TafaMidisFx 10066-Benzoxazolecarboxylic acid, 2-(3,5-dichlorophenyl)-Tafamidis(Fx 1006)2-(3,5-Dichlorophenyl)-6-benzoxazole carboxylic acidFx 1006AFx1006A
CAS NO. 1454846-35-5 Lorlatinib
Product Name: Lorlatinib Other Name: PF-06463922
CAS No.: 1454846-35-5
CAS:951395-08-7 Tafamidis Meglumine 99%
Tafamidis Meglumine CAS:951395-08-7 ITEMS
Categories
High Quality Products
Send Us a Message
We didn't put all products on website. If you can't find the product you're looking for, please contact us for more information.
Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.
Fill in more information so that we can get in touch with you faster
Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.